(Q43673136)

25 November 2017

title

Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling (English)

1 reference

25 November 2017

1 reference

6

Shinsaku Fukuda

1 reference

25 November 2017

Yuki Satoh

1

1 reference

25 November 2017

Yoh Ishiguro

2

1 reference

25 November 2017

Hirotake Sakuraba

3

1 reference

25 November 2017

Shogo Kawaguchi

4

1 reference

25 November 2017

Hiroto Hiraga

5

1 reference

25 November 2017

Akio Nakane

7

1 reference

25 November 2017

publication date

16 July 2009

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

25 November 2017

published in

1 reference

25 November 2017

volume

297

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

G514-9

1 reference

Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Effect of cyclosporine in a murine model of experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Inflammatory bowel disease, past, present and future: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

The mechanism of action of cyclosporin A and FK506

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Disrupted barrier function through epithelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

High Fas ligand expression on lymphocytes in lesions of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Critical role for c-FLIP(L) on Fas resistance in colon carcinoma cell line HT-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

Epithelial NEMO links innate immunity to chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.90608.2008

21 January 2018

Identifiers

DOI

10.1152/AJPGI.90608.2008

1 reference

25 November 2017

1 reference